THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT AND DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY OUTSIDE INDIA.

EXIM ROUTES LIMITED

(Previously Known as Exim Routes Private Limited)

Corporate Identity Number: U51909HR2019PLC115525

* Based on Restated Standalone Financial Statements.

* Based on Restated Standalone Financial Statements.

NAV = Net worth excluding preference share capital and revaluation reserve/Outstanding number of Equity shares outstanding during the year or period.

Our company considers that KPIs included herein below have a bearing for arriving at the basis for Offer Price. The KPIs disclosed below have been approved by a resolution of our Audit Committee dated November 21, 2025. Further, the KPIs herein have been certified by M/s NKSC & Co., Chartered Accountants, by their certificate dated November 21, 2025, vide UDIN 25521986BMNYYZ6487. Additionally, the Audit Committee on its meeting dated November 21, 2025, have confirmed that other than verified and audited KPIs set out below, our company has not disclosed to earlier investors at any point of time during the three-year period prior to the date of the Draft Red Herring Prospectus.

For further details of our key performance indicators, see "Risk Factors, "Our Business", "Management's Discussion and Analysis of Financial Condition and Results of Operations" on pages 37, 212 and 310 respectively. We have described and defined them, where applicable, in "Definitions and Abbreviations" section on page no. 2. Our Company confirms that it shall continue to disclose all the KPIs included in this section "Basis for Offer Price", on a periodic basis, at least once in a year (or for any lesser period as determined by the Board of our Company), for a duration that is at least the later of (i) one year after the listing date or period specified by SEBI; or (ii) till the utilization of the Net Proceeds. Any change in these KPIs, during the aforementioned period, will be explained by our Company as required under the SEBI ICDR Regulations.

The Issue was being made through the Book Building Process, in terms of Rule 19(2)(b)(i) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 253 of the SEBI ICDR Regulations, as amended, wherein not more than 50% of the Net Issue was available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBS", the "QIB Portion"), Our Company in consultation with the Book Running Lead Manager has allocated upto 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations ("Anchor Investor Portion"). Further, not less than 15% of the Net Issue was made available for allocation on a proportionate basis to Non-Institutional Bidders (out of which one third was reserved for applicants with an application size of more than two lots and upto such lots equivalent to not more 10,00,000 and two-thirds was reserved for applicants with application size of more than 10,00,000) and not less than 35% of the Net Issue was made available for allocation to Individual Investors in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Issue Price. Further, Equity Shares were allocated on a proportionate basis to Eligible Employees applying under the Employee Reservation Portion, subject to valid Bids being received at or above the Issue Price. All potential Bidders (except Anchor Investors) were required to mandatorily utilise the Application Supported by Blocked Amount ("ASBA") process providing details of their respective ASBA accounts, and UPI ID in case of Individual Investors using the UPI Mechanism, if applicable, in which the corresponding Bid Amounts will be blocked by the SCSBs or by the Sponsor Bank under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors we re not permitted to participate in the Issue through the ASBA process. For details, see "Issue Procedure" beginning on page 375 of the Prospectus. The investors are advised to refer to the Prospectus for the full text of the Disclaimer clause pertaining to NSE. For the purpose of this Issue, the designated Stock Exchange will be the NSE Limited. The trading is proposed to be commenced on or before December 19, 2025*

*Subject to the receipt of listing and trading approval from the NSE ("NSE Emerge").

The bidding for Anchor Investors opened and closed on December 11, 2025. The Company received a total of 04 Anchor Investor Application Forms from 04 Anchor Investors for 14,49,600 Equity Shares and the aggregate amount collected from applications made by such Anchor Investors was Rs. 12,75,64,800/-. A total of 14,11,200 Equity Shares were allocated under the Anchor Investor Portion at Rs. 88/- per Equity Share (including a share premium of Rs. 83/- per Equity Share) aggregating to Rs. 12,41,85,600.

The Issue (excluding Anchor Investors Portion) received 6,732 Applications for 5,07,80,800 Equity Shares (before technical rejections) resulting in 16.64 times subscription (including reserved portion of market maker). The details of the Applications received in the Issue from various categories are as under (before technical rejections):

A summary of the final demand as per NSE as on the Bid/Issue Closing Date at different Bid prices is as under:

The Basis of Allotment was finalised in consultation with the Designated Stock Exchange, being NSE Limited on December 17, 2025.

The Basis of Allotment to the Individual Investors, who have Bid at cut-off Price or at or above the Issue Price of Rs. 88/- per Equity Share, was finalized in consultation with NSE Limited. The category has been subscribed to the extent of 9.89 times. The total number of Equity Shares Allotted in this category is 16,57,600 Equity Shares to 1036 successful applicants. The details of the Basis of Allotment of the said category is as under:

The Basis of Allotment to the Non-Institutional Investors, who have Bid at cut-off Price or at or above the Issue Price of Rs. 88/- per Equity Share, was finalized in consultation with NSE Limited. The category has been subscribed to the extent of 11.70 times. The total number of Equity Shares Allotted in this category is 2,40,000 Equity Shares to 50 successful applicants. The details of the Basis of Allotment of the said category is as under:

The Basis of Allotment to the Non-Institutional Investors, who have Bid at cut-off Price or at or above the Issue Price of Rs. 88/- per Equity Share, was finalized in consultation with NSE Limited. The category has been subscribed to the extent of 26.63 times. The total number of Equity Shares Allotted in this category is 4,70,400 Equity Shares to 98 successful applicants. The details of the Basis of Allotment of the said category is as under:

Allotment to QIBs, who have bid at the Issue Price of Rs. 88/- per Equity Share or above, has been done on a proportionate basis in consultation with NSE Limited. This category has been subscribed to the extent of 19.10 times of QIB portion. The total number of Equity Shares allotted in the QIB category is 9,40,800 Equity Shares, which were allotted to 12 successful Applicants.

5) Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to Market Maker who have bid at Issue Price of Rs. 88/- per Equity Shares or above, was finalized in consultation with NSE Limited. The category was subscribed 1.00 times i.e. for 2,49,600 Equity Shares the total number of shares allotted in this category is 2,49,600 Equity Shares. The category wise details of the Basis of Allotment are as under:

The Company in consultation with the BRLM has allocated 14,11,200 Equity Shares to 04 Anchor Investors at the Anchor Investor issue price of Rs. 88/- per Equity Shares accordance with the SEBI ICDR Regulations. This represents 60% of the QIB Category

The Board of Directors of our Company at its meeting held on December 17, 2025, has taken on record the basis of allotment of Equity Shares approved by the Designated Stock Exchange, being NSE Limited and has allotted the Equity Shares to various successful applicants.

The Allotment Advice Cum Refund Intimation will be dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs have been dispatched/ mailed for unblocking of funds and transfer to the Public Issue Account on or before December 11, 2025, and payment to non-Syndicate brokers have been issued on December 18, 2025. In case the same is not received within ten days, investors may contact the Registrar to the Issue at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the Emerge Platform of NSE Limited within three working days from the date of the closure of the issue.

Note: All capitalized terms used and not defined herein shall have the respective meaning assigned to them in the Prospectus dated December 17, 2025 ("Prospectus").

Referring to Page No. 100 of Prospectus under the Chapter "Capital Structure". Number of locked in Shares as on the date of this advertisement is

The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Maashitla Securities Private Limited at www.maashitla.com

All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

	MAASHITLA SECURITIES PRIVATE LIMITED
	451, Krishna Apra Business Square, Netaji Subhash Place, Pitampura, Delhi - 110034, India
	Contact Person: Mr. Mukul Agrawal
	Tel: 011-47581432
	Fax: N.A Email: ipo@maashitla.com
	Investor grievance e-mail: investor.ipo@maashitla.com
	Website: www.maashitla.com
	SEBI Registration No.: INR000004370

Disclaimer: Exim Routes Limited is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its Equity Shares and has filed the Prospectus with the Registrar of Companies, Delhi, on December 17, 2025, and thereafter with SEBI and the Stock Exchange. The Prospectus is available on the website of NSE EMERGE at https://www.nseindia.com/market-data/all-upcoming-issues-ipo and is available on the websites of the BRLM at www.narnolia.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the Prospectus including the section titled "Risk Factors" beginning on page 37 of the Prospectus.

The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended or any state securities laws in the United States, and unless so registered, and may not be issued or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, 1933 and in accordance with any applicable U.S. State Securities laws. The Equity Shares are being issued and sold outside the United States in ‘offshore transactions' in reliance on Regulation "S" under the Securities Act, 1933 and the applicable laws of each jurisdiction where such issues and sales are made. There will be no public offering in the United States.